Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
433.20
+0.37 (0.09%)
At close: Mar 9, 2026, 4:00 PM EDT
433.00
-0.20 (-0.05%)
After-hours: Mar 9, 2026, 6:44 PM EDT
Madrigal Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -288.28 | -465.89 | -373.63 | -295.35 | -241.85 | |
| Depreciation & Amortization | 4.72 | 1.1 | 0.53 | 0.47 | 0.41 | |
| Other Amortization | 1.6 | 2.09 | 2.41 | 0.8 | - | |
| Stock-Based Compensation | 98.13 | 79.88 | 49.74 | 31.63 | 26.87 | |
| Other Operating Activities | 2.78 | -0.4 | - | - | - | |
| Change in Accounts Receivable | -80.65 | -53.82 | - | - | - | |
| Change in Inventory | -36.98 | -34.07 | - | - | - | |
| Change in Accounts Payable | 5.28 | 15.56 | 4.21 | 2.45 | 20.36 | |
| Change in Other Net Operating Assets | 103.86 | -0.01 | -7.49 | 35.15 | 10.29 | |
| Operating Cash Flow | -189.55 | -455.57 | -324.23 | -224.86 | -183.92 | |
| Capital Expenditures | -0.47 | -1.46 | -1.48 | -0.22 | -0.21 | |
| Sale (Purchase) of Intangibles | -3 | -5 | - | - | - | |
| Investment in Securities | 35.79 | -267.92 | -501.04 | 206.9 | -4.85 | |
| Investing Cash Flow | 32.32 | -274.39 | -502.52 | 206.69 | -5.06 | |
| Long-Term Debt Issued | 350 | - | 65 | 50 | - | |
| Total Debt Issued | 350 | - | 65 | 50 | - | |
| Long-Term Debt Repaid | -121.66 | - | - | - | - | |
| Net Debt Issued (Repaid) | 228.34 | - | 65 | 50 | - | |
| Issuance of Common Stock | 38.06 | 735.06 | 530.48 | 264.34 | 171.24 | |
| Other Financing Activities | -10.41 | - | -0.36 | -0.89 | - | |
| Financing Cash Flow | 255.98 | 735.06 | 595.12 | 313.45 | 171.24 | |
| Foreign Exchange Rate Adjustments | 0.01 | - | - | - | - | |
| Net Cash Flow | 98.76 | 5.1 | -231.63 | 295.28 | -17.74 | |
| Free Cash Flow | -190.02 | -457.03 | -325.71 | -225.07 | -184.13 | |
| Free Cash Flow Margin | -19.83% | -253.72% | - | - | - | |
| Free Cash Flow Per Share | -8.47 | -21.48 | -17.43 | -13.13 | -11.13 | |
| Levered Free Cash Flow | -115.08 | -296.99 | -192.38 | -115.68 | -94.62 | |
| Unlevered Free Cash Flow | -102.74 | -289.91 | -186.85 | -114 | -94.62 | |
| Change in Working Capital | -8.5 | -72.35 | -3.28 | 37.6 | 30.65 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.